Cite
HARVARD Citation
Weycker, D. et al. (2017). Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis based on real-world data from 2010 to 2015. Current medical research and opinion. pp. 2115-2120. [Online].